TrialClinical and translational medicine2024

Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.

Tian-Mei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.